April 27, 2025 1:14 AM

Latest:

Westhaven Gold PEA: Small Mining Projects See Massive Value Surge
Orogen Royalties: Triple Flag’s $421 Million Acquisition
Lumina Gold’s $581 Million Buyout: The Start of A Junior Mining M&A Wave?
Elemental Altus Q4 Earnings: How $3,300 Gold Rescued a Missed Production Target
Newmont Q1 Earnings: Gold Boom Masks Production Problems

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Home
Latest
- Automotive
- Cannabis
- Commentary
- Full Analysis
- Gold
- Industrials
- Macro
- Oil
- Resources
- Technology
Resources
Energy
Technology
Coverage Companies
Verses AI
About
Contact Us

Bill C-71 Canada to Restore Citizenship Rights for ‘Lost Canadians’ and Their Descendants

Latest

Westhaven Gold PEA: Small Mining Projects See Massive Value Surge
Orogen Royalties: Triple Flag’s $421 Million Acquisition
Lumina Gold’s $581 Million Buyout: The Start of A Junior Mining M&A Wave?
Elemental Altus Q4 Earnings: How $3,300 Gold Rescued a Missed Production Target
Newmont Q1 Earnings: Gold Boom Masks Production Problems
A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley – Cardiol Therapeutics
How One Mining Stock Delivered 3,200% Returns | Wojtek Wodzicki – NGEx Minerals
Long Live the King? Canadians Would Rather Rejoin British Empire Than Become 51st US State

Video

Westhaven Gold PEA: Small Mining Projects See Massive Value Surge

April 26, 2025 5:36 PM Jay Lutz 0

The insane rise in the price of gold is starting to have a major impact on projects coming down the

A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley - Cardiol Therapeutics
How One Mining Stock Delivered 3,200% Returns | Wojtek Wodzicki - NGEx Minerals
Liberals Appoint Wife of Bloc Québécois Leader to Head Federal Research Foundation
Lumina Gold's $581 Million Buyout: The Start of A Junior Mining M&A Wave?
Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million

News

Biotech Latest News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Leave a ReplyCancel reply